Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 173, Issue 7, 2006, Pages 798-802

  Willers, Elisabeth D ^a   Newman, John H ^b   Loyd, James E ^b   Robbins, Ivan M ^b   Wheeler, Lisa A ^b   Prince, Melissa A ^b   Stanton, Krista C ^b   Cogan, Joy A ^b   Runo, James R ^b   Byrne, Daniel ^b   Humbert, Marc ^b   Simonneau, Gerald ^b   Sztrymf, Benjamin ^b   Morse, Jane A ^b   Knowles, James A ^b   Roberts, Kari E ^b   McElroy, Jude J ^b   Barst, Robyn J ^b   Phillips III, John A ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

5 HT; 5 HTT; Familial pulmonary arterial hypertension; Idiopathic pulmonary arterial hypertension; Primary pulmonary hypertension; Serotonin transporter

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR; SEROTONIN TRANSPORTER;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL;

ADULT; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION, PULMONARY; MALE; MUTATION; POLYMORPHISM, GENETIC; PROGNOSIS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 33645300735     PISSN: 1073449X     EISSN: 1073449X     Source Type: Journal    
DOI: 10.1164/rccm.200509-1361OC     Document Type: Article

References (22)

1. Newman JH, Trembath RC, Morse JA, Grunig E, Loyd JE, Adnot S, Coccolo F, Ventura C, Phillips JA III, Knowles JA, et al. Genetic basis of pulmonary arterial hypertension: current understanding and future directions. J Am Coll Cardiol 2004;43(12, Suppl S):33S-39S.
2. Newman JH, Fanburg BL, Archer SL, Badesch DB, Barst RJ, Garcia JG, Kao PN, Knowles JA, Loyd JE, McGoon MD, et al. Pulmonary arterial hypertension: future directions: report of a National Heart, Lung and Blood Institute/Office of Rare Diseases workshop. Circulation 2004;109:2947-2952.
3. Cogan JD, Vnencak-Jones CL, Phillips JA III, Lane KB, Wheeler LA, Robbins IM, Garrison G, Hedges LK, Loyd JE, et al. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet Med 2005;7:169-174.
4. Loyd JE, Primm RK, Newman JH. Familial primary pulmonary hypertension: clinical patterns. Am Rev Respir Dis 1984;129:194-197.
5. Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, Ward K, Yacoub M, Mikhail G, Rogers P, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000;37:741-745.
6. Eddahibi S, Fabre V, Boni C, Martres MP, Raffestin B, Hamon M, Adnot S. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells: relationship with the mitogenic action of serotonin. Circ Res 1999;84:329-336.
7. Marcos E, Fadel E, Sanchez O, Humbert M, Dartevelle P, Simonneau G, Hamon M, Adnot S, Eddahibi S. Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertension. Circ Res 2004;94:1263-1270.
8. Herve P, Drouet L, Dosquet C, Launay JM, Rain B, Simonneau G, Caen J, Duroux P. Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med 1990;89:117-120.
9. Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, Poubeau P, Cerrina J, Duroux P, Drouet L. Increased plasma serotonin in primary pulmonary hypertension. Am JMed 1995;99:249-254.
10. Eddahibi S, Hanoun N, Lanfumey L, Lesch KP, Raffestin B, Hamon M, Adnot S. Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene. J Clin Invest 2000;105:1555-1562.
11. MacLean MR, Sweeney G, Baird M, McCulloch KM, Houslay M, Morecroft I. 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br J Pharmacol 1996;119:917-930.
12. Eddahibi S, Raffestin B, Hamon M, Adnot S. Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension? J Lab Clin Med 2002;139:194-201.
13. Lesch KP, Balling U, Gross J, Strauss K, Wolozin BL, Murphy DL, Riederer P. Organization of the human serotonin transporter gene. J Neural Transm Gen Sect 1994;95:157-162.
14. Lesch KP,Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
15. Eddahibi S, Humbert M, Fadel E, Raffestin B, Darmon M, Capron F, Simonneau G, Dartevelle P, Hamon M, Adnot S. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J Clin Invest 2001;108:1141-1150.
16. Eddahibi S, Chaouat A, Morrell N, Fadel E, Fuhrman C, Bugnet AS, Dartevelle P, Housset B, Hamon M, Weitzenblum E, et al. Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease. Circulation 2003;108:1839-1844.
17. Willers ED, Newman JH, Loyd JE, Robbins IM, Wheeler LA, Prince MA, Cogan JD, Phillips JA III. Serotonin transporter (SERT) promoter polymorphisms and age of onset in familial and idiopathic pulmonary arterial hypertension (PAH). Poster presented at the American Thoracic Society conference, San Diego, CA, May 22, 2005.
18. Rothman RB, Ayestas MA, Dersch CM, Baumann MH. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates: implications for primary pulmonary hypertension. Circulation 1999;100:869-875.
19. Lee SL, Wang WW, Fanburg BL. Dexfenfluramine as a mitogen signal via the formation of superoxide anion. FASEB J 2001;15:1324-1325.
20. Guignabert C, Raffestin B, Benferhat R, Raoul W, Zadigue P, Rideau D, Hamon M, Adnot S, Eddahibi S. Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats. Circulation 2005;111:2812-2819.
21. Sztrymf B, Francoual J, Sitbon O, Labrune P, Jambou M, Pous C, Simonneau G, Humbert M. Clinical, haemodynamic and genetic features of familial pulmonary arterial hypertension. Rev Mal Respir 2004;21:909-915.
22. Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med 2003;167:580-586.